Jiwa Bio-Pharm (HKG:2327) FY12 net profit $71M, dn 72%; div 2.1 ct - ResearchInChina

Search by Type

Report DataBase News

*

Search by Company

Code Company name

Category

Home>>News>>Life Sciences>>Pharmaceutical>>Pharmaceutical

Remember Me Next Time

Jiwa Bio-Pharm (HKG:2327) FY12 net profit $71M, dn 72%; div 2.1 ct

Date:2012-05-25

Related Company

Jiwa Bio-Pharm Holdings Limited(02327.HK)

Results of Jiwa Bio-Pharm Holdings (HKG:2327) for the fiscal year ended 31 March 2012:

Net profit: HK$70.62M, down 72.38% YoY
EPS: HK 4.39 cents
Final dividend: HK 2.1 cents

Source:chinesestock.org

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Chemical Pharmaceutical Industry Report, 20112012-01-17
China Pharmaceutical Equipment Industry Report, 2011-20122011-12-28
China Animal Vaccine Industry Report, 2010-20112011-08-18
China Human Vaccine Industry Report, 2010-20112011-05-27
China Pharmaceutical Chain Industry Report, 20102010-12-14
China Chemical Pharmaceutical Industry Report, 2009-20102010-12-08
China Vaccine Industry Report, 2009-20102010-09-26
China Animal Vaccine Industry Report, 2009-20102010-06-25

Related News

Jiwa Bio-Pharm (HKG:2327) FY12 net profit $71M, dn 72%; div 2.1 ct2012-05-25
Controllers Up Stakes In Fosun Pharma, Hongbaoli2012-02-24
Huahai Pharma 2011 Earnings Up 131%2012-02-22
Hisun Pharma To Set Up JV With Pfizer2012-02-21
Wyeth seeks $960 million in damages from Sun Pharma2012-02-17
GlaxoSmithKline Pharmaceuticals net sales up 15.4%2012-02-17
China to Expand Drug List, Health Minister Says; Price Cuts Seen2012-02-17
China Renji (HKG:0648) Buys Brilliant Oasis at $165M2012-02-15

Contact us | Copyright | Privacy policy | Buy Reports | Member Service | Mailing List

2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1